LB Pharmaceuticals (NASDAQ:LBRX) Cut to Strong Sell at Wall Street Zen
Wall Street Zen downgraded shares of LB Pharmaceuticals (NASDAQ:LBRX – Free Report) from a sell rating to a strong sell rating in a research report report published on Saturday morning,Wall Street Zen reports. Several other research firms have also recently weighed in on LBRX. Wolfe Research began coverage on LB Pharmaceuticals in a research report […]
6 Oct 06:03 · The Markets Daily